美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Ciprofloxacin/Ciprofloxacin HCl (AB)	Tablet (Extended Release)	II (Paddle)	50	0.1 N HCl	900	15, 30, 60, and 120	2008/01/14
Ciprofloxacin/Dexamethasone	Otic Suspension			Develop a method to characterize in vitro release			2016/03/17
Citalopram	Capsule			Refer to FDA's Dissolution Guidance, 2018			2023/07/07
Citalopram HBr	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Citalopram Hydrobromide	Capsule	II (Paddle)	50	0.1 N HCl	900	10, 20, 30 and 45	2008/10/06
Cladribine	Tablet	II (Paddle)	50	Phosphate Buffer, pH 6.8 (deaerated)	900	5, 10, 15, 20 and 30	2022/05/12
Clarithromycin	Tablet (Extended Release)			Refer to USP			2008/10/06
Clarithromycin	Suspension	II (Paddle)	50	0.05 M Phosphate Buffer, pH 6.8	900	10, 20, 30, 45 and 60	2004/01/23
Clarithromycin	Tablet			Refer to USP			2007/07/25
Clevidipine	Emulsion			Develop a dissolution method			2025/09/08
Clindamycin HCl	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Clobazam	Tablet	II (Paddle)	75	0.1 N HCl (degassed)	900	5, 10, 20, 30, 45 and 60	2013/07/31
Clobazam	Oral Suspension	II (Paddle)	75	0.1 N HCl (degassed)	900	5, 10, 15, 20, 25 and 30	2013/07/31
Clobazam	Film	V (Paddle over Disk), with 56 mm, 40 mesh stainless steel disk.	75	0.1 N HCl	900	2, 5, 10, 15, 20 and 30	2021/04/22
Clomiphene Citrate	Tablet			Develop a dissolution method			2024/01/03
Clomipramine HCl	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Clonazepam	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Clonazepam	Suspension			Develop a dissolution method			2024/11/01
Clonazepam	Tablet (Orally Disintegrating)			Develop a dissolution method			2023/09/15
Clonidine	Transdermal			Refer to USP			2009/02/18